MFIM
ELV icon

Mesirow Financial Investment Management’s Elevance Health ELV Stock Holding History

Mesirow Financial Investment Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,139
Closed -$369K – 509
2025
Q3 		$369K Buy
1,139
+150
+15% +$46.7K 0.01% 411
2025
Q2 		$385K Buy
989
+224
+29% +$90.1K 0.01% 400
2025
Q1 		$333K Buy
765
+99
+15% +$39.7K 0.01% 431
2024
Q4 		$246K Buy
666
+111
+20% +$46.4K ﹤0.01% 507
2024
Q3 		$289K Buy
555
+62
+13% +$33.1K 0.01% 458
2024
Q2 		$268K Buy
493
+17
+4% +$8.99K 0.01% 428
2024
Q1 		$247K Buy
476
+33
+7% +$16.4K 0.01% 457
2023
Q4 		$209K Buy
+443
New +$205K 0.01% 515

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Mesirow Financial Investment Management's ELV Position: Q4 2025 in Review

Mesirow Financial Investment Management sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,139 shares — an estimated $369K sold.

Mesirow Financial Investment Management first reported a position in ELV in Q4 2023 and held it in 8 quarters. The position peaked at $385K in Q2 2025. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Mesirow Financial Investment Management reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Mesirow Financial Investment Management sold 1,139 Elevance Health shares in Q4 2025, an estimated $369K.
  • Mesirow Financial Investment Management first reported a position in Elevance Health in Q4 2023 and held it in 8 quarters.
  • Mesirow Financial Investment Management's Elevance Health position peaked at $385K in Q2 2025.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Mesirow Financial Investment Management's 13F filing for Q4 2025, filed 5 Feb 2026.